The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia
Abstract
Rationale Hyponatremia and dexamethasone resistance in polydipsic schizophrenic patients are attributable to changes in hippocampal-modulated antidiuretic and stress hormone activity, respectively. The relationship of the neuroendocrine findings to the psychiatric illness, however, is unknown. An impaired ability to identify facial emotions has been linked to core features of schizophrenia and to diminished levels of the closely related hormone, oxytocin, in the polydipsic subset. Intranasal oxytocin enhances facial affect discrimination in healthy subjects.Objective The aim of this study is to explore if oxytocin reverses impaired facial affect discrimination in schizophrenic patients with, relative to that in patients without, polydipsia.Methods Intranasal oxytocin (10 or 20 IU) and placebo were administered on three occasions to five polydipsic schizophrenic patients, eight nonpolydipsic patients, and 11 healthy controls. Subsequently, subjects rated the presence and intensity of six facial emotions.Results Emotion recognition fell in both patient groups following 10 IU of oxytocin due to an increased propensity to identify all emotions regardless of whether they were displayed. By contrast, emotion recognition improved following 20 IU in polydipsic relative to nonpolydipsic patients due primarily to divergent effects on the bias to identify fear in nonfearful faces.Conclusion The effects of 20 IU oxytocin support the hypothesis that altered neuroendocrine function in polydipsic patients contributes to their psychiatric illness. Further studies are warranted to confirm these findings and assess if oxytocin treatment improves social functioning in this subset. This is the first psychopharmacologic study to compare different doses of oxytocin in the same subject, thus the significance of the opposing responses is unclear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies that have controlled for dose show important dose-dependent variation on physiology (Cardoso et al., 2013) or social cognition (Goldman et al., 2011; Hall et al., 2012).”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Goldman et al., 2011
In the citing paper
“Middle doses (20–24 IU) have the greatest positive effects, whereas low (10 IU) or high doses (48 IU) show blunted effects (Goldman et al., 2011; Hall et al., 2012; Cardoso et al., 2013).”
From Endogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a review (2014) · cites this paper as Goldman et al., 2011
In the citing paper
“In schizophrenic patients, intranasal OT increased emotion recognition at one dose (20 IU) and decreased emotion recognition at a different dose (10 IU) (23).”
From Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles (2013) · cites this paper as [23]
In the citing paper
“A clinical study with divergent single-dose oxytocin administration in patients with schizophrenia showed that 20 IU oxytocin, but not 10 IU oxytocin, ameliorated emotion recognition deficits in a polydipsic group.18”
From Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial (2016) · cites this paper as [18]
In the citing paper
“Only a few studies examined the differential effects of higher (24, 40 or 48 IU) and lower (10, 20 or 24 IU, respectively) oxytocin doses [103-105].”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
In the citing paper
“In these studies the dose around 20 IU (24 IU or 20 IU) had more favorable effects compared to the other dose studied (48, 40 or 10 IU).”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
In the citing paper
“However, these studies were single administration studies on non-clinical outcome measures.”
From Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial (2014) · cites this paper as [103]
Citations
Cites
Baron‐Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00715 · Cited by 4,555 · cited 1×
“Pictures were a subset from Ekman and Friesen (1976) previously used to demonstrate altered responses in facial affect discrimination in patients with amygdala pathology (Adolphs et al. 1999), autism ( Baron-Cohen et al. 2001 ), and schizophrenia (Addington et al. 2006).”
MethodEkman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Baron‐Cohen, S., Wheelwright, S. J., Hill, J., Raste, Y., & Plumb, I. (2001) · PubMed · Cited by 4,313
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091
Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans
Kirsch, P., Esslinger, C., Chen, Q., Mier, D., Lis, S., Siddhanti, S., Gruppe, H., Mattay, V. S., Gallhofer, B., & Meyer-Lindenberg, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3984-05.2005 · Cited by 1,639
Neuroendocrine perspectives on social attachment and love
Sue Carter, C. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00055-9 · Cited by 1,425
Oxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298
Contributions to Neuropsychological Assessment
Sarazin, F. (1996) · Europe PMC (PubMed Central) · Cited by 1,151
Facial Emotion Perception in Schizophrenia: A Meta-analytic Review
Kohler, C. G., Walker, J. B., Martin, E. A., Healey, K. M., & Moberg, P. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn192 · Cited by 991
Contributions to Neuropsychological Assessment
Greene, J. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.3.346 · Cited by 825
Oxytocin, vasopressin, and human social behavior
Heinrichs, M., von Dawans, B., & Domes, G. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.005 · Cited by 799
Facial Emotion Recognition in Schizophrenia: Intensity Effects and Error Pattern
Kohler, C. G., Turner, T. H., Bilker, W. B., Brensinger, C. M., Siegel, S. J., Kanes, S., Gur, R. E., & Gur, R. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1768 · Cited by 782
Recognition of facial emotion in nine individuals with bilateral amygdala damage
Adolphs, R., Tranel, D., Hamann, S. B., Young, A. W., Calder, A. J., Phelps, E. A., Anderson, A. K., Lee, G. P., & Damásio, A. R. (1999) · Neuropsychologia · doi:10.1016/s0028-3932(99)00039-1 · Cited by 778
Oxytocin attenuates amygdala responses to emotional faces regardless of valence
Domes, G., Heinrichs, M., Gläscher, J., Büchel, C., Braus, D. F., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.025 · Cited by 774 · cited 5×
“…for Marsh et al. (2010), Di Simplicio et al. (2009), and Fisher-Shofty et al. (2010) more closely resembled those of the current study, but all three utilized morphed, not static, stimuli, and FisherShofty et al. subjects, like those in the Domes et al. (2007b) study, viewed only the eye region.”
BackgroundResultInfluentialOxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans
Hurlemann, R., Patin, A., Onur, O. A., Cohen, M. X., Baumgartner, T., Metzler, S., Dziobek, I., Gallinat, J., Wagner, M., Maier, W., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5538-09.2010 · Cited by 771
Processing of facial emotion expression in major depression: a review
Bourke, C., Douglas, K., & Porter, R. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.496359 · Cited by 557
Effects of intranasal oxytocin on emotional face processing in women
Domes, G., Lischke, A., Berger, C., Grossmann, A., Hauenstein, K., Heinrichs, M., & Herpertz, S. C. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.016 · Cited by 521 · cited 2×
“Furthermore, some oxytocin effects vary markedly by gender (Domes et al. 2010), but our sample was too small to address gender effects.”
BackgroundDifferent amygdala subregions mediate valence-related and attentional effects of oxytocin in humans
Gamer, M., Zurowski, B., & Büchel, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000985107 · Cited by 487 · cited 2×
“Intranasal oxytocin enhances facial affect discrimination (Marsh et al. 2007) and specifically reduces detection of fear in nonfearful faces (Fischer-Shofty et al. 2010) perhaps by diminishing amygdala activity (Kirsch et al. 2005; Domes et al. 2007a; Gamer et al. 2010).”
BackgroundFacial affect recognition: A mediator between cognitive and social functioning in psychosis?
ADDINGTON, J., Saeedi, H., & Addington, D. E. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.028 · Cited by 345
Oxytocin improves specific recognition of positive facial expressions
Marsh, A. A., Yu, H. H., Pine, D. S., & Blair, R. J. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1780-4 · Cited by 321
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients
Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308
Accurate identification of fear facial expressions predicts prosocial behavior.
Marsh, A. A., Kozak, M. N., & Ambady, N. (2007) · Emotion · doi:10.1037/1528-3542.7.2.239 · Cited by 288
de León, J., Verghese, C., Tracy, J. I., Josiassen, R. C., & Simpson, G. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90008-6 · Cited by 279
Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin
Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.042 · Cited by 270
Gur, R. E., Loughead, J., Kohler, C. G., Elliott, M. A., Lesko, K., Ruparel, K., Wolf, D. H., Bilker, W. B., & Gur, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.12.1356 · Cited by 236
Di Simplicio, M., Massey-Chase, R., Cowen, P., & Harmer, C. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108095705 · Cited by 229
Salonia, A., Nappi, R. E., Pontillo, M., Daverio, R., Smeraldi, A., Briganti, A., Fabbri, F., Zanni, G. E., Rigatti, P., & Montorsi, F. (2004) · Hormones and Behavior · doi:10.1016/j.yhbeh.2004.10.002 · Cited by 229
Peripheral oxytocin is associated with reduced symptom severity in schizophrenia
Rubin, L. H., Carter, C. S., Drogos, L. L., Pournajafi‐Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.014 · Cited by 228
Goldman, M. B., Marlow-O’Connor, M., Torres, I. J., & Carter, C. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.019 · Cited by 216
Impairment in the Specificity of Emotion Processing in Schizophrenia
Schneider, F. W., Gur, R. C., Koch, K., Backes, V., Amunts, K., Shah, N. J., Bilker, W. B., Gur, R. E., & Habel, U. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.442 · Cited by 215
Social cognition in schizophrenia: a review of face processing
Marwick, K., & Hall, J. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn035 · Cited by 214
Kucharska‐Pietura, K., David, A. S., Masiak, M., & Phillips, M. L. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.187.6.523 · Cited by 213
Overactivation of Fear Systems to Neutral Faces in Schizophrenia
Hall, J., Whalley, H. C., McKirdy, J. W., Romaniuk, L., McGonigle, D. J., McIntosh, A. M., Baig, B. J., Gountouna, V., Job, D. E., Donaldson, D. I., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.014 · Cited by 195
The effect of intranasal administration of oxytocin on fear recognition
Fischer-Shofty, M., Shamay-Tsoory, S. G., Harari, H., & Levkovitz, Y. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.09.003 · Cited by 184
Sharing secrets: oxytocin and trust in schizophrenia
Kéri, S., Kiss, I., & Kelemen, O. (2009) · Social Neuroscience · doi:10.1080/17470910802319710 · Cited by 167
Sustained activation of the hippocampus in response to fearful faces in schizophrenia
Holt, D. J., Weiss, A. P., Rauch, S. L., Wright, C. I., Zalesak, M., GOFF, D. C., Ditman, T., Welsh, R. C., & Heckers, S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.033 · Cited by 143
Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21604 · Cited by 135
Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating
Feifel, D., & Reza, T. L. (1999) · Psychopharmacology · doi:10.1007/s002130050811 · Cited by 121
Oxytocin Links Mothering Received, Mothering Bestowed and Adult Stress Responses
Pedersen, C. A., & Boccia, M. L. (2002) · Stress · doi:10.1080/1025389021000037586 · Cited by 120
Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice
Caldwell, H. K., Stephens, S. L., & Young, W. S. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002150 · Cited by 108
Addington, J., Girard, T. A., Christensen, B. K., & Addington, D. E. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.080039 · Cited by 100
Goldman, M. B. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830170069010 · Cited by 99
Goghari, V. M., MacDonald, A. W., & Sponheim, S. R. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq046 · Cited by 97
Tsoi, D. T., Lee, K.-H., Khokhar, W. A., Mir, N. U., Swalli, J. S., Gee, K. A., Pluck, G., & Woodruff, P. W. R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.006 · Cited by 92
Intranasal oxytocin in obsessive-compulsive disorder
Epperson, C. N., McDougle, C. J., & Price, L. H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)00120-5 · Cited by 88
Impaired facial emotion recognition and reduced amygdalar volume in schizophrenia
Namiki, C., Hirao, K., Yamada, M., Hanakawa, T., Fukuyama, H., Hayashi, T., & Murai, T. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.03.004 · Cited by 80
ORGANIC FUNCTIONS IN SCHIZOPHRENIA
Hoskins, R. G. (1933) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1933.02240130131008 · Cited by 75
Goldman, M. B. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.06.004 · Cited by 59
Hawken, E. R., Crookall, J. M., Reddick, D., Millson, R. C., Milev, R. V., & Delva, N. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.029 · Cited by 56
Goldman, M. B., Gnerlich, J. L., & Hussain, N. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301282 · Cited by 40
Poirier, S., Legris, G., Tremblay, P., Michea, R., Viau-Guay, L., Mérette, C., Bouchard, R.-H., Maziade, M., & Roy, M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.036 · Cited by 32
Goldman, M. B., Blake, L., Marks, R., Hedeker, D., & Luchins, D. J. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.653 · Cited by 32
Goldman, H. H. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1535 · Cited by 31
Bralet, M., Ton, T., & Falissard, B. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.11.009 · Cited by 24
Structural pathology underlying neuroendocrine dysfunction in schizophrenia
Goldman, M. B., Wang, L., Wachi, C., Daudi, S., Csernansky, J. G., Marlow-O’Connor, M., Keedy, S., & Torres, I. J. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.025 · Cited by 24
Attribution Biases in Schizophrenia: Relationship to Clinical and Functional Impairments
Cohen, A. S., Nienow, T. M., Dinzeo, T. J., & Docherty, N. M. (2008) · Psychopathology · doi:10.1159/000173702 · Cited by 23
Olfactory deficits in patients with schizophrenia and severe polydipsia
Kopala, L. C., Good, K. P., Koczapski, A. B., & Honer, W. G. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00436-8 · Cited by 21
Seifer, D. B., Sandberg, E. C., Ueland, K., & Sladen, R. N. (1985) · PubMed · Cited by 20
Association between stereotypic behavior and polydipsia in chronic schizophrenic patients
Shutty, M. S., Mcculley, K., & Pigott, B. (1995) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(95)00049-6 · Cited by 19
Torres, I., Keedy, S., Marlow-O’Connor, M., Beenken, B., & Goldman, M. (2009) · Neuropsychology · doi:10.1037/a0014481 · Cited by 17
Estimating daily urine volume in psychiatric patients: Empiric confirmation
Goldman, M. B., Marks, R., Blake, L. M., Petkovic, M., Hedeker, D., & Luchins, D. J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90343-x · Cited by 12
Vieweg, W. V. R., Godleski, L., Hundley, P. L., & Yan, G. R. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90059-6 · Cited by 3
Research works printed but not linked: 1
- Targowla R (1923) Des troubles fonctionnel du rein dans les maladies mentales. L’excretion del’eau (Kidney malfunction and mental illness: water excretion). Bull Mém Soc Méd Hôp Paris 47:1711–1715
Cited by
Sorted by citations
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688
Is oxytocin “nature’s medicine”
Carter, C. S., Kenkel, W. M., MacLean, E. L., Wilson, S. R., Perkeybile, A. M., Yee, J. R., Ferris, C. F., Nazarloo, H. P., Porges, S. W., Davis, J. M., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019398 · Cited by 394
Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.34 · Cited by 383
Shahrestani, S., Kemp, A. H., & Guastella, A. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.86 · Cited by 283
Cochran, D. M., Fallon, D., Hill, M., & Frazier, J. A. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0b013e3182a75b7d · Cited by 267
Metadata
- Authors
- Goldman, M. B., Gomes, A. M., Carter, C. S., & Lee, R.
- Affiliations
- Northwestern University (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Corresponding author
- Goldman, Morris B.
- Venue
- Psychopharmacology
- Published
- 2011-02-09
- Volume
- 216
- Issue
- 1
- Pages
- 101-110
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2071486937
- Cited by
- 112
- References
- 62
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 6 · 2015: 12 · 2014: 24 · 2013: 20 · 2012: 10
- FWCI
- 25.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Institutes of Health
- National Institute of Mental Health (R21MH082295)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cognitive Neuroscience › Face Recognition and Perception
- Keywords
- intranasal oxytocin, polydipsia, schizophrenia, facial emotion recognition, dose-dependent effects, hyponatremia, dexamethasone resistance, neuroendocrine dysfunction, vasopressin, stress hormones
- MeSH terms
- Administration, Intranasal, Adult, Dose-Response Relationship, Drug, Double-Blind Method, Emotions, Facial Expression, Female, Humans, Male, Middle Aged, Oxytocin, Pilot Projects, Schizophrenia, Schizophrenic Psychology, Thirst, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
